Meet us at the American
Diabetes Association’s
83rd Scientific Sessions

Dexcom Warrior with Dexcom G7 and G7 App

Prescribe
Dexcom G7 for
confident diabetes management

The next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available to prescribe for patients with all types of diabetes. Dexcom G7 is clinically proven to reduce A1C, increase time in range, reduce hyper- and hypoglycemia, and improve quality of life.^1-5

Smart device sold separately*

Accuracy Icon

The most accurate CGM⁶

simple icon

The simple CGM

#1 covered icon

#1 covered CGM brand⁷

You’re invited to our Dexcom product theatre^†

Saturday, June 24 | 3:00 – 3:45 p.m. PT | Product Theatre 1

Introducing Dexcom G7: Simplicity, solutions, and success for your patients and your practice

New data is emerging on the use of Dexcom CGM and its impact on the clinical and psychosocial health for those with type 2 diabetes (T2D). This program will review recently published outcomes that contributed to Medicare expanding coverage for CGM, like Dexcom G7 for the management of people with T2D on basal insulin in the US. Additionally, we will examine recent findings on the prevalence of hypoglycemia in Medicare populations, and demonstrate how RT-CGM, like Dexcom G7, may provide support and improve glycemic outcomes for older adults with T2D. Hear from the experts regarding the best practices on implementing Dexcom G7 in clinical practice, and learn new strategies to use TIR data to simplify the review of CGM reports. Finally, take a look at recent innovations and connections now available with Dexcom G7 designed to ease the burden of diabetes management.

Speakers

nicholas argento

NICHOLAS ARGENTO, MD, FACE

Diabetes Technology Director, Maryland Endocrine and Diabetes

thomas martens

THOMAS MARTENS, MD, FACP

Medical Director, International Diabetes Center, Park Nicollet Clinic and HealthPartners Care

Livestream/recordings

The presentation will be livestreamed on the conference virtual platform and enduring until August 28. Attendees can also view after the conference on-demand on our free SIGMA platform.

†This program is not part of the American Diabetes Association’s 83rd Scientific Sessions as planned by the American Diabetes Association. This event is neither sponsored nor endorsed by the American Diabetes Association. This event does not qualify for continuing medical education (CME) credit.

Check out our new interactive booth

Explore and compare
Dexcom CGM products
with live demos

panelist podium icon

Engage with experts at
exclusive in-booth
presentations

touch screen icon

Learn about Dexcom’s
connected partners through
an interactive experience

Dexcom podcast: real-time real-talk

Dexcom’s clinical education team will be recording live interviews with healthcare professionals and other guests on Saturday and Sunday

“Real-Time Real-Talk” is an exceptional podcast tailored to healthcare providers and everyone involved in diabetes treatment. Its monthly episodes are packed with an impressive array of guests, including healthcare professionals, Dexcom Warriors, and industry experts, who offer their unique perspectives on topics related to continuous glucose monitoring (CGM). Recordings will be available to listen to here:

LISTEN TO PODCASTS

In-booth presentations

Members from the Dexcom Clinical Education team will be presenting several in booth talks throughout the conference. On Saturday and Sunday we will also have a Made for Connection Series featuring presentations by our AID partners.

deb greenwood

DEB GREENWOOD, PHD, RN, BC-ADM, CDCES, FADCES

Senior Manager, Clinical Education | Global Marketing | Dexcom

jami klein

JAMI KLEIN RN, BSN, CDCES

Manager, Clinical Education | Global Marketing |
Dexcom

jennifer wenzel

JENNIFER WENZEL-WAMHOFF, PHARMD, BC-ADM, CDCES

Manager, Clinical Education | Global Marketing | Dexcom

emily newbold

EMILY NEWBOLD, PHD, RD, CDCES

Manager, Clinical Education | Global Marketing | Dexcom

Date	Time	Presentation	Presentation Title
Friday, June 23, 2023	7:00 - 7:15 p.m.	Clinical Education	First Look at the Dexcom G7 Feature Utilization
Saturday, June 24, 2023	11:00 - 11:15 a.m.	Clinical Education	First Look at the Dexcom ONE User Experience Dexcom ONE is not available for sale or distribution in the United States.
	11:30 - 11:45 a.m.	Clinical Education	The Role of Dexcom G7 with the New, Expanded CGM Medicare Coverage to Help Prevent Hypoglycemia
	1:40 - 2:10 p.m.	Made for Connections Series	he Power of Dexcom AID Systems
	2:30 - 2:45 p.m.	Clinical Education	First Look at the Dexcom G7 Feature Utilization
Sunday, June 25, 2023	11:30 - 11:45 a.m.	Clinical Education	Your Next Prescription for Type 2 Diabetes Management: Dexcom G7
	12:15 - 12:30 p.m.	Clinical Education	First Look at the Dexcom ONE User Experience Dexcom ONE is not available for sale or distribution in the United States
	1:40 - 2:10 p.m.	Made for Connections Series	The Power of Dexcom AID Systems
	2:30 - 2:45 p.m.	Clinical Education	The Role of Dexcom G7 with the New, Expanded CGM Medicare Coverage to Help Prevent Hypoglycemia
Monday, June 26, 2023	11:30 - 11:45 a.m.	Clinical Education	Your Next Prescription for Type 2 Diabetes Management: Dexcom G7

A live and virtual event

Real-Time Continuous Glucose Monitoring

Going Beyond the Obvious

An accredited medical education hybrid event, supported by an independent educational grant from Dexcom. Available on medscape.org for on demand view after the ADA conference.

DETAILS HERE

medscape brochure

*For a list of compatible devices, visit www.dexcom.com/compatibility.

1 Beck RW, et al. JAMA. 2017;317(4):371-378. 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3 Martens T, et al. JAMA. 2021;325(22):2262-2272. 4 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 6 Dexcom, data on file, 2022. 7 Managed Markets Insights & Technology, LLC MMIT Analytics, June 2022.

LBL-1004082 REV001

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request for Patient Materials on Dexcom CGM

More Information on Dexcom

Request a Sample

Other

Please note: To ensure a successful transaction, please provide information that matches the Provider's medical license information.

Dexcom G7 samples are the only version currently available online.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider's medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

Meet us at the American Diabetes Association’s83rd Scientific Sessions

Prescribe Dexcom G7 forconfident diabetes management

The most accurate CGM6